National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 5) (No. PB 68 of 2013) (Cth)

PB 68 of 2013

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 5)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the

Minister for Health and Medical Research, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                17           September 2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 5).

(2)   This Determination may also be cited as PB 68 of 2013.

1. Commencement

This Determination commences on 1 October 2013.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Zoledronic acid

Omit

Zolmitriptan

[2]     Schedule 2, after item dealing with Vinorelbine

Insert

Zolmitriptan